Hunan Jiudian Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥11.85 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.96
Forward PE	16.94
Price to Sales TTM	CN¥4.02
Price to Book MRQ	CN¥4.91
Enterprise to Revenue	3.85
Enterprise to EBITDA	18.48

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	17.25%
Operating Margin	29.49%
Return on Assets TTM	10.77%
Return on Equity TTM	23.68%

Income Statement

Revenue TTM	CN¥2,945,467,904
Revenue per Share TTM	CN¥6.12
Quarterly Revenue Growth	15.50%
Gross Profit TTM	CN¥2,077,294,284
EBITDA	CN¥572,904,295
Net Income to Common TTM	CN¥508,005,152
Diluted EPS TTM	CN¥1.04
Quarterly Earnings Growth YoY	47.40%

Balance Sheet

Total Cash MRQ	CN¥710,038,720
Total Cash per Share MRQ	CN¥1.45
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	15.42
Current Ratio MRQ	4.23
Book Value per Share MRQ	CN¥4.87

Cash Flow

Operating Cash Flow TTM	CN¥645,972,032
Levered Free Cash Flow TTM	CN¥-65,299,080

300705 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	496,185,984
Float Shares	411,793,212
Avg 10 Volume	5,559,991
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.98%
% Held by Institutions	20.46%

Stock Price Summary

Beta	0.55
Fifty Two Week Low	CN¥15.02
Fifty Two Week High	CN¥28.75
Fifty Two Week Change	-40.89%
Day 50 MA	CN¥24.44
Day 200 MA	CN¥24.67

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.28
Forward Annual Dividend Yield	8.23%
Trailing Annual Dividend Rate	CN¥0.32
Trailing Annual Dividend Yield	2.06%
Payout Ratio	30.74%
Dividend Date
Ex Dividend Date	2024-05-24
Last Split Factor
Last Split Date	2024-05-24